Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Administration without resuspension; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in product usage process in a female patient who received HAB (Twinrix) for prophylaxis. On 06-NOV-2025, the patient received Twinrix. On 06-NOV-2025, an unknown time after receiving Twinrix, the patient experienced wrong technique in product usage process (Verbatim: Administration without resuspension). The outcome of the wrong technique in product usage process was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-NOV-2025 The pharmacist reported that they forgot to resuspend Twinrix before administration. The patient received Twinrix vaccine but the dose was not resuspended. The patient was maybe 60 or 65 years old, the health care professional was not sure about the patient's age. The health care professional did not provide more information about the lot number or expiration date of Twinrix. The reporter was ask did the patient need to be revaccinated. What was the recommendations for this situation. The batch number was not provided upon follow up with the reporter.